The slip
PARKINSON RECEIPTno. 13159
28 Oct 2026, 15:44 UTCdopamine neurons, braak
predictionZMYM4 in dopamine neurons tracks Braak Lewy-body stage
registeredefd7a02087bece63
discovery-0.50 p=0.168 n=9
replication-0.03 p=0.946 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.50, p 0.168)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT680dbadfff326366db224154…
follows a4b6917235f6…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 13159: ZMYM4 in dopamine neurons, braak
- power
- full sample -0.17 (p 0.504, n 18), 95% CI -0.59 to +0.32. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.11 (p 0.658, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.04 (p 0.874, n 18). could be the mix.
- skeptic
- leave-one-out range -0.33 to -0.08, sign flips 0; without severely affected donors -0.17 (p 0.504, n 18). fragile.
- cell type
- strongest in OPCs: -0.63 (p 0.0047, n 18) vs -0.17 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ZMYM4 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up ZMYM4 · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.40 p 0.155 (needs p < 1.7e-4)